Respiratory Virus–Specific Nasopharyngeal Lipidome Signatures and Severity in Infants With Bronchiolitis: A Prospective Multicenter Study
The Journal of Infectious Diseases · 2023
DOI: 10.1093/infdis/jiad156 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift The Journal of Infectious Diseases, 2023. Verfasst von Michihito Kyo und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Emergency Medicine, Massachusetts General Hospital, Harvard Medical School. Hauptthemen laut MEDLINE: Respiratory Syncytial Virus Infections, Bronchiolitis, Respiratory Syncytial Virus, Human, Viruses. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIH HHS, NIAID NIH HHS, NIH.
Abstract (Originalsprache)
Background
In infant bronchiolitis, recent evidence indicates that respiratory viruses (eg, respiratory syncytial virus [RSV], rhinovirus [RV]) contribute to the heterogeneity of disease severity. Of the potential pathobiological molecules, lipids serve as signaling molecules in airway inflammation. However, little is known about the role of the airway lipidome in between-virus heterogeneity and disease severity.
Methods
In this multicenter prospective study of 800 infants hospitalized for RSV or RV bronchiolitis, we analyzed nasopharyngeal lipidome data. We examined discriminatory lipids between RSV and RV infection and the association of the discriminatory lipids with bronchiolitis severity, defined by positive pressure ventilation (PPV) use.
Results
We identified 30 discriminatory nasopharyngeal lipid species and 8 fatty acids between RSV and RV infection. In the multivariable models adjusting for patient-level confounders, 8 lipid species—for example, phosphatidylcholine (18:2/18:2) (adjusted odds ratio [aOR], 0.23 [95% confidence interval {CI}, .11–.44]; false discovery rate [FDR] = 0.0004) and dihydroceramide (16:0) (aOR, 2.17 [95% CI, 1.12–3.96]; FDR = 0.04)—were significantly associated with the risk of PPV use. Additionally, 6 fatty acids—for example, eicosapentaenoic acid (aOR, 0.27 [95% CI, .11–.57]; FDR = 0.01)—were also significantly associated with the risk of PPV use.
Conclusions
In infants hospitalized for bronchiolitis, the nasopharyngeal lipidome plays an important role in the pathophysiology of between-virus heterogeneity and disease severity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Emergency Medicine, Massachusetts General Hospital, Harvard Medical School.
- Department of Pediatrics, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts.
ORCID-Profile: Michihito Kyo
Förderung
- NIH HHS
- NIAID NIH HHS
- NIH
Zitieren
APA
Kyo, M., Zhu, Z., Shibata, R., Fujiogi, M., Mansbach, J. M., Camargo, C. A., & Hasegawa, K. (2023). Respiratory Virus–Specific Nasopharyngeal Lipidome Signatures and Severity in Infants With Bronchiolitis: A Prospective Multicenter Study. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiad156
Vancouver
Kyo M, Zhu Z, Shibata R, Fujiogi M, Mansbach JM, Camargo CA, et al. Respiratory Virus–Specific Nasopharyngeal Lipidome Signatures and Severity in Infants With Bronchiolitis: A Prospective Multicenter Study. The Journal of Infectious Diseases. 2023. doi:10.1093/infdis/jiad156
BibTeX
@article{Kyo2023,
author = {Kyo, Michihito and Zhu, Zhaozhong and Shibata, Ryohei and Fujiogi, Michimasa and Mansbach, Jonathan M and Camargo, Carlos A and Hasegawa, Kohei},
title = {Respiratory Virus–Specific Nasopharyngeal Lipidome Signatures and Severity in Infants With Bronchiolitis: A Prospective Multicenter Study},
journal = {The Journal of Infectious Diseases},
year = {2023},
doi = {10.1093/infdis/jiad156}
}
EUVIMED